Linfoma T/NK extranodal tipo nasal de localização atípica na orofaringe
DOI:
https://doi.org/10.34631/sporl.251Palavras-chave:
Linfoma T/NK, orofaringeResumo
O linfoma de células T/NK constitui um subtipo raro de linfoma nasosinusal, previamente conhecido por granuloma letal da linha média, caracterizando-se pela destruição progressiva das estruturas medio-faciais. Existe uma forte associação com a infecção pelo vírus Epstein-Barr. Apresenta-se o caso clínico de uma mulher de 43 anos com linfoma T/NK extranodal do tipo nasal com localização atípica na orofaringe. Apesar da sua raridade, existem actualmente esquemas terapêuticos bem definidos. Contudo, o prognóstico permanece geralmente desfavorável.
Referências
McBride P. Photographs of a case of rapid destruction of the nose and face. J Laryngol Otol 1897; 12: 64-66.
Vidal RW et al. Sinonasal malignant lymphomas: a distinct clinicopa-thological category. Ann Otol Rhinol Laryngol 1999; 108(4): 411-9.
Cheung MM, Chan JK, Lau, Foo W. Primary non-Hodgkin lymphoma of the nose and nasopharynx: Clinical features, tumor immunophenotype, and treatment outcome in 113 patients. JClin Oncology 1998; 16:70-7.
Harris NL, Jaffe ES, Stein HS, Banks PM, Chan JKC, Cleary ML, et al. A Revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood
; 84: 1361-92.
Yoshifumi I et al. Nasal T-cell lymphoma as a type of so-called "Lethal midline granuloma". Cancer 1982; 50: 2336-2344.
Tsokos M, Fauci AS, Costa J, Idiopathic midline destructive disease (IMDD). A subgroup of patients with the "midline granuloma" syndrome. Am J Clin Pathol 1982; 77: 162-8.
Senan S. Malignant centrofacial granulomas. Laryngoscope 1992. 102(4): 472.
Chan J, Ng CS, Lau WH, Stephen TH. Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms. Am J Surg Pathol 1987; 11:418-29.
Hartig G, Montone K, Wasik M, Chalian A, Hayden R. Nasal T-cell lymphoma and the lethal midline granuloma syndrome. Otolaryngol Head Neck Surg 1996; 114: 653-656.
Cleary KR, Batsakis JG. Sinonasal lymphomas. Ann Otol Rhinol Laryngol 1994; 103: 911-914.
Petrella T, Delfau-Larue MH, Caillot D, et al. Nasopharyngeal lymphomas: further evidence for a natural killer origin. Hum Pathol 1996; 27: 827-33.
Harabuchi Y et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. The Lancet1990; 20:128-130.
Peiper SC. Angiocentric lymphoproliferative disorders of the respiratory system: incrimination of Epstein-Barr virus in pathogenesis. Blood 1993; 82: 687-90.
Nagata H, et al. Characterization of novel natural killer (NK)-cell and yõ T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein-Barr virus. Blood 2001. 97(3): 708-13.
Braunwald E et al., Harrison's Principles of Internal Medicine. 15th ed. Chapter 112. Malignancies of Lymphoid Cells. McGaw-Hill 2001. 715-727.
Myamoto T, Yoshino T, Takehisa T, et al. Cutaneous presentation of nasal/nasal type T/NK cell lymphoma: clinicopathological findings of four cases. Int J Dermatol 1997; 36(6): 419-27.
Cummings CW, Donegan J. Otolaryngology - Head and Neck Surgery. Mosby 1993, Chapter 93 - Lymphomas 1758-1763.
Borges A et al. Midline destructive lesions of the sinonasal tract: Simplified terminology based on histopathologic criteria. AJNR Am J Neuroradiol 2000; 21: 331-336.
Skarin A. Lethal midline granuloma revisited: Nasal T/ Natural-Killer cell lymphoma. J Clin Oncology 1999; 17: 1322-1325.
Miller TP, Dahlberg MS, Cassady JR, Adelstein DJ, Spier CM, Grogan TM, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate and high grade non-Hodgkin lymphoma. N Eng J Med 1998; 339: 21-6.
